Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2025-03-24 00:00:00 ET · period of report 2025-03-20 · accession 0001104659-25-027336 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-24 | 2025-03-21 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | S - Sale+OE | $54.23 | -344 | 2,889 | -11% | -$18.7K |
| D | 2025-03-24 | 2025-03-20 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | M - OptEx | — | +1,163 | 3,233 | +56% | — |
| D | 2025-03-24 | 2025-03-20 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | M - OptEx | $0.00 | -1,163 | 2,324 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-21 | S | D | 344 | $54.23 | 2,889 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-20 | M | A | 1,163 | — | 3,233 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 3 | Derivative | Restricted Stock Units | 2025-03-20 | M | D | 1,163 | $0.00 | 2,324 | D | — · — to — | 1,163 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F3) The restricted stock units have vested or will vest as to 25% of the total shares on each of March 20, 2024, March 20, 2025, March 20, 2026 and March 20, 2027, subject to the Reporting Person's continued service on each such vesting date. The restricted stock units have no expiration date. |